Detalhe da pesquisa
1.
Cross-talk between mutant p53 and p62/SQSTM1 augments cancer cell migration by promoting the degradation of cell adhesion proteins.
Proc Natl Acad Sci U S A
; 119(17): e2119644119, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439056
2.
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
Proc Natl Acad Sci U S A
; 118(23)2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088837
3.
Deciphering the involvement of the Hippo pathway co-regulators, YAP/TAZ in invadopodia formation and matrix degradation.
Cell Death Dis
; 14(4): 290, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37185904
4.
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients.
Nat Commun
; 13(1): 2800, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589715
5.
A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Cancer Res
; 80(19): 4145-4157, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816858
6.
New insights into YAP/TAZ nucleo-cytoplasmic shuttling: new cancer therapeutic opportunities?
Mol Oncol
; 13(6): 1335-1341, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050214
7.
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.
Cell Death Dis
; 9(10): 985, 2018 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30250159